» Articles » PMID: 30504459

An ATF6-tPA Pathway in Hepatocytes Contributes to Systemic Fibrinolysis and is Repressed by DACH1

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2018 Dec 4
PMID 30504459
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-type plasminogen activator (tPA) is a major mediator of fibrinolysis and, thereby, prevents excessive coagulation without compromising hemostasis. Studies on tPA regulation have focused on its acute local release by vascular cells in response to injury or other stimuli. However, very little is known about sources, regulation, and fibrinolytic function of noninjury-induced systemic plasma tPA. We explore the role and regulation of hepatocyte-derived tPA as a source of basal plasma tPA activity and as a contributor to fibrinolysis after vascular injury. We show that hepatocyte tPA is downregulated by a pathway in which the corepressor DACH1 represses ATF6, which is an inducer of the tPA gene Hepatocyte-DACH1-knockout mice show increases in liver , circulating tPA, fibrinolytic activity, bleeding time, and time to thrombosis, which are reversed by silencing hepatocyte Conversely, hepatocyte-ATF6-knockout mice show decreases in these parameters. The inverse correlation between DACH1 and / is conserved in human liver. These findings reveal a regulated pathway in hepatocytes that contributes to basal circulating levels of tPA and to fibrinolysis after vascular injury.

Citing Articles

Peripheral blood RNA biomarkers can predict lesion severity in degenerative cervical myelopathy.

Zheng Z, Chen J, Xu J, Jiang B, Li L, Li Y Neural Regen Res. 2024; 20(6):1764-1775.

PMID: 39104114 PMC: 11688566. DOI: 10.4103/NRR.NRR-D-23-01069.


Connecting impaired fibrinolysis and dyslipidemia.

Rodriguez M, Zheng Z Res Pract Thromb Haemost. 2024; 8(3):102394.

PMID: 38706781 PMC: 11066549. DOI: 10.1016/j.rpth.2024.102394.


Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.

Zhang Z, Rodriguez M, Zheng Z Arterioscler Thromb Vasc Biol. 2024; 44(3):533-544.

PMID: 38235555 PMC: 10922732. DOI: 10.1161/ATVBAHA.123.318286.


Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages.

Lebrun F, Levard D, Lemarchand E, Yetim M, Furon J, Potzeha F Blood Adv. 2024; 8(5):1330-1344.

PMID: 38190586 PMC: 10943589. DOI: 10.1182/bloodadvances.2023011744.


Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.

Zhang Z, Dai W, Zhu W, Rodriguez M, Lund H, Xia Y Res Pract Thromb Haemost. 2023; 7(6):102164.

PMID: 37680312 PMC: 10480648. DOI: 10.1016/j.rpth.2023.102164.


References
1.
Mu X, Espanol-Suner R, Mederacke I, Affo S, Manco R, Sempoux C . Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest. 2015; 125(10):3891-903. PMC: 4607132. DOI: 10.1172/JCI77995. View

2.
Samson A, Medcalf R . Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron. 2006; 50(5):673-8. DOI: 10.1016/j.neuron.2006.04.013. View

3.
Wang X, Zheng Z, Caviglia J, Corey K, Herfel T, Cai B . Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2017; 24(6):848-862. PMC: 5226184. DOI: 10.1016/j.cmet.2016.09.016. View

4.
Ozcan L, Ghorpade D, Zheng Z, Cristina de Souza J, Chen K, Bessler M . Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. Cell Rep. 2016; 15(10):2214-2225. PMC: 5068925. DOI: 10.1016/j.celrep.2016.05.006. View

5.
Collen D, Lijnen H . The tissue-type plasminogen activator story. Arterioscler Thromb Vasc Biol. 2009; 29(8):1151-5. DOI: 10.1161/ATVBAHA.108.179655. View